NNOX
Nano-X Imaging Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$0.79
+10.83%Year over year
Reported trailing growth
- Revenue
- +25.7%
- EBITDA
- -10.5%
- EBIT
- -6.4%
- EPS
- -26.7%
- Free cash flow
- -25.7%
- Operating cash flow
- -21.4%
Forward estimates
Based on analyst estimates
- Revenue
- +146.5%
- EBITDA
- +59.6%
- EPS
- +59.3%
Three-year CAGR
- Revenue
- +14.9%
- EBITDA
- -8.9%
- EBIT
- -7.0%
- Net income
- -40.2%
- EPS
- -27.5%
- Free cash flow
- -14.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026